|
1
|
Karousis ED and Mühlemann O:
Nonsense-mediated mRNA decay begins where translation ends. Cold
Spring Harb Perspect Biol. 11:a0328622019. View Article : Google Scholar
|
|
2
|
Huang L, Low A, Damle SS, Keenan MM, Kuntz
S, Murray SF, Monia BP and Guo S: Antisense suppression of the
nonsense mediated decay factor Upf3b as a potential treatment for
diseases caused by nonsense mutations. Genome Biol. 19:42018.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jaffrey SR and Wilkinson MF:
Nonsense-mediated RNA decay in the brain: Emerging modulator of
neural development and disease. Nat Rev Neurosci. 19:715–728. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Celik A, He F and Jacobson A: NMD monitors
translational fidelity 24/7. Curr Genet. 63:1007–1010. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Popp MW and Maquat LE: Nonsense-mediated
mRNA decay and cancer. Curr Opin Genet Dev. 48:44–50. 2018.
View Article : Google Scholar :
|
|
6
|
Huang L, Lou CH, Chan W, Shum EY, Shao A,
Stone E, Karam R, Song HW and Wilkinson MF: RNA homeostasis
governed by cell type-specific and branched feedback loops acting
on NMD. Mol Cell. 43:950–961. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lu J, Plank TD, Su F, Shi X, Liu C, Ji Y,
Li S, Huynh A, Shi C, Zhu B, et al: The nonsense-mediated RNA decay
pathway is disrupted in inflammatory myofibroblastic tumors. J Clin
Invest. 126:3058–3062. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mendell JT, Sharifi NA, Meyers JL,
Martinez-Murillo F and Dietz HC: Nonsense surveillance regulates
expression of diverse classes of mammalian transcripts and mutes
genomic noise. Nat Genet. 36:1073–1078. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Liu C, Karam R, Zhou Y, Su F, Ji Y, Li G,
Xu G, Lu L, Wang C, Song M, et al: The UPF1 RNA surveillance gene
is commonly mutated in pancreatic adenosquamous carcinoma. Nat Med.
20:596–598. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Goetz AE and Wilkinson M: Erratum to:
Stress and the nonsense-mediated RNA decay pathway. Cell Mol Life
Sci. 74:40472017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Stoll SW, Johnson JL, Li Y, Rittié L and
Elder JT: Amphiregulin carboxy-terminal domain is required for
autocrine keratinocyte growth. J Invest Dermatol. 130:2031–2040.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tinhofer I, Klinghammer K, Weichert W,
Knödler M, Stenzinger A, Gauler T, Budach V and Keilholz U:
Expression of amphiregulin and EGFRvIII affect outcome of patients
with squamous cell carcinoma of the head and neck receiving
cetuximab-docetaxel treatment. Clin Cancer Res. 17:5197–5204. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Shao J, Lee SB, Guo H, Evers BM and Sheng
H: Prostaglandin E2 stimulates the growth of colon cancer cells via
induction of amphiregulin. Cancer Res. 63:5218–5223.
2003.PubMed/NCBI
|
|
14
|
Stabile LP, Rothstein ME, Keohavong P,
Lenzner D, Land SR, Gaither-Davis AL, Kim KJ, Kaminski N and
Siegfried JM: Targeting of both the c-Met and EGFR pathways results
in additive inhibition of lung tumorigenesis in transgenic mice.
Cancers (Basel). 2:2153–2170. 2010. View Article : Google Scholar
|
|
15
|
Cook PW, Pittelkow MR, Keeble WW,
Graves-Deal R, Coffey RJ and Shipley GD: Amphiregulin messenger RNA
is elevated in psoriatic epidermis and gastrointestinal carcinomas.
Cancer Res. 52:3224–3227. 1992.PubMed/NCBI
|
|
16
|
Cook PW, Piepkorn M, Clegg CH, Plowman GD,
DeMay JM, Brown JR and Pittelkow MR: Transgenic expression of the
human amphiregulin gene induces a psoriasis-like phenotype. J Clin
Invest. 9:2286–2294. 2004.
|
|
17
|
Chung E, Cook PW, Parkos CA, Park YK,
Pittelkow MR and Coffey RJ: Amphiregulin causes functional
downregulation of adherens junctions in psoriasis. J Invest
Dermatol. 124:1134–1140. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Swindell WR, Xing X, Stuart PE, Chen CS,
Aphale A, Nair RP, Voorhees JJ, Elder JT, Johnston A and Gudjonsson
JE: Heterogeneity of inflammatory and cytokine networks in chronic
plaque psoriasis. PLoS One. 7:e345942012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Nair RP, Duffin KC, Helms C, Ding J,
Stuart PE, Goldgar D, Gudjonsson JE, Li Y, Tejasvi T, Feng BJ, et
al: Genome-wide scan reveals association of psoriasis with IL-23
and NF-kappaB pathways. Nat Genet. 41:199–204. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Reischl J, Schwenke S, Beekman JM,
Mrowietz U, Stürzebecher S and Heubach JF: Increased expression of
Wnt5a in psoriatic plaques. J Invest Dermatol. 127:163–169. 2007.
View Article : Google Scholar
|
|
21
|
Yao Y, Richman L, Morehouse C, de los
Reyes M, Higgs BW, Boutrin A, White B, Coyle A, Krueger J, Kiener
PA and Jallal B: Type I interferon: Potential therapeutic target
for psoriasis? PLoS One. 3:e27372008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Suárez-Fariñas M, Li K, Fuentes-Duculan J,
Hayden K, Brodmerkel C and Krueger JG: Expanding the psoriasis
disease profile: Interrogation of the skin and serum of patients
with moderate-to-severe psoriasis. J Invest Dermatol.
132:2552–2564. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Qiu CC, Su QS, Zhu SY and Liu RC:
Identification of potential biomarkers and biological pathways in
juvenile dermatomyositis based on miRNA-mRNA network. Biomed Res
Int. 2019:78142872019. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lv M, Deng J, Tang N, Zeng Y and Lu C:
Efficacy and safety of tripterygium wilfordii Hook F on psoriasis
vulgaris: A systematic review and meta-analysis of randomized
controlled trials. Evid Based Complement Alternat Med.
2018:26230852018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Medicine DC oPLAAoTC: Consensus on
diagnosis and treatment of Chinese integrative medicine for
psoriasis vulgaris. Chin J Dermatol Venerol Integ Tradit West Med.
8:3282009.
|
|
26
|
Oka T, Sugaya M, Takahashi N, Takahashi T,
Shibata S, Miyagaki T, Asano Y and Sato S: CXCL17 attenuates
imiquimod-induced psoriasis-like skin inflammation by recruiting
myeloid-derived suppressor cells and regulatory T cells. J Immunol.
198:3897–3908. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
28
|
Ueyama A, Yamamoto M, Tsujii K, Furue Y,
Imura C, Shichijo M and Yasui K: Mechanism of pathogenesis of
imiquimod-induced skin inflammation in the mouse: A role for
interferon-alpha in dendritic cell activation by imiquimod. J
Dermatol. 41:135–143. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Amer M, Mostafa FF, Tosson Z and Nasr AN:
Corneocytes in scaly parakeratotic diseases. Int J Dermatol.
35:417–421. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Stoll SW, Stuart PE, Lambert S,
Gandarillas A, Rittié L, Johnston A and Elder JT: Membrane-tethered
intracellular domain of amphiregulin promotes keratinocyte
proliferation. J Invest Dermatol. 136:444–452. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chan WK, Huang L, Gudikote JP, Chang YF,
Imam JS, MacLean JA and Wilkinson MF: An alternative branch of the
nonsense-mediated decay pathway. EMBO J. 26:1820–1830. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lou CH, Shao A, Shum EY, Espinoza JL,
Huang L, Karam R and Wilkinson MF: Posttranscriptional control of
the stem cell and neurogenic programs by the nonsense-mediated RNA
decay pathway. Cell Rep. 6:748–764. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Nelson JO, Moore KA, Chapin A, Hollien J,
Metzstein MM. Degradation of Gadd45 mRNA by nonsense-mediated decay
is essential for viability. Elife. 5:e128762016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Feng Q, Snider L, Jagannathan S, Tawil R,
van der Maarel SM, Tapscott SJ and Bradley RK: A feedback loop
between nonsense-mediated decay and the retrogene DUX4 in
facioscapu-lohumeral muscular dystrophy. Elife. 4:2015. View Article : Google Scholar
|
|
35
|
Li Y, Stoll SW, Sekhon S, Talsma C, Camhi
MI, Jones JL, Lambert S, Marley H, Rittié L, Grachtchouk M, et al:
Transgenic expression of human amphiregulin in mouse skin:
Inflammatory epidermal hyperplasia and enlarged sebaceous glands.
Exp Dermatol. 25:187–193. 2016. View Article : Google Scholar :
|
|
36
|
Patel GK, Wilson CH, Harding KG, Finlay AY
and Bowden PE: Numerous keratinocyte subtypes involved in wound
re-epitheli-alization. J Invest Dermatol. 126:497–502. 2006.
View Article : Google Scholar
|
|
37
|
Ruiz N, Wang B, Pentland A and Caparon M:
Streptolysin O and adherence synergistically modulate
proinflammatory responses of keratinocytes to group A streptococci.
Mol Microbiol. 27:337–346. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Hurt JA, Robertson AD and Burge CB: Global
analyses of UPF1 binding and function reveal expanded scope of
nonsense-mediated mRNA decay. Genome Res. 23:1636–1650. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Fiorini F, Boudvillain M and Le HH: Tight
intramolecular regulation of the human Upf1 helicase by its N- and
C-terminal domains. Nucleic Acids Res. 41:2404–2415. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Schweingruber C, Rufener SC, Zünd D,
Yamashita A and Mühlemann O: Nonsense-mediated mRNA
decay-mechanisms of substrate mRNA recognition and degradation in
mammalian cells. Biochim Biophys Acta. 1829:612–623. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Sun Y, Xiao S, Chen J, Wang M, Zheng Z,
Song S and Zhang L: Heat shock protein 90 mediates the apoptosis
and autophage in nicotinic-mycoepoxydiene-treated HeLa cells. Acta
Biochim Biophys Sin (Shanghai). 47:451–458. 2015. View Article : Google Scholar
|
|
42
|
Li X, Xu H, Xu C, Lin M, Song X, Yi F,
Feng Y, Coughlan KA, Cho WC, Kim SS and Cao L: The yin-yang of DNA
damage response: Roles in tumorigenesis and cellular senescence.
Int J Mol Sci. 14:2431–2448. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Stoll SW, Stuart PE, Swindell WR, Tsoi LC,
Li B, Gandarillas A, Lambert S, Johnston A, Nair RP and Elder JT:
The EGF receptor ligand amphiregulin controls cell division via
FoxM1. Oncogene. 35:2075–2086. 2016. View Article : Google Scholar :
|
|
44
|
Albanesi C, De Pità O and Girolomoni G:
Resident skin cells in psoriasis: A special look at the
pathogenetic functions of keratinocytes. Clin Dermatol. 25:581–588.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Lai Y, Li D, Li C, Muehleisen B, Radek KA,
Park HJ, Jiang Z, Li Z, Lei H, Quan Y, et al: The antimicrobial
protein REG3A regulates keratinocyte proliferation and
differentiation after skin injury. Immunity. 37:74–84. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Zaiss DMW, Gause WC, Osborne LC and Artis
D: Emerging functions of amphiregulin in orchestrating immunity,
inflammation, and tissue repair. Immunity. 42:216–226. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Schmucker H, Blanding WM, Mook JM, Wade
JF, Park JP, Kwist K, Shah H and Booth BW: Amphiregulin regulates
proliferation and migration of HER2-positive breast cancer cells.
Cell Oncol (Dordr). 41:159–168. 2018. View Article : Google Scholar
|
|
48
|
Stoll SW, Rittié L, Johnson JL and Elder
JT: Heparin-binding EGF-like growth factor promotes
epithelial-mesenchymal transition in human keratinocytes. J Invest
Dermatol. 132:2148–2157. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Farley SM, Purdy DE, Ryabinina OP,
Schneider P, Magun BE and Iordanov MS: Fas ligand-induced
proinflammatory transcriptional responses in reconstructed human
epidermis. Recruitment of the epidermal growth factor receptor and
activation of MAP kinases. J Biol Chem. 283:919–928. 2008.
View Article : Google Scholar
|
|
50
|
Kennedy-Crispin M, Billick E, Mitsui H,
Gulati N, Fujita H, Gilleaudeau P, Sullivan-Whalen M, Johnson-Huang
LM, Suárez-Fariñas M and Krueger JG: Human keratinocytes' response
to injury upregulates CCL20 and other genes linking innate and
adaptive immunity. J Invest Dermatol. 132:105–113. 2012. View Article : Google Scholar
|
